{"id":"https://openalex.org/W1980418252","doi":"https://doi.org/10.1021/js980378j","title":"Role of P\u2010glycoprotein\u2010mediated secretion in absorptive drug permeabiity: An approach using passive membrane permeability and affinity to P\u2010glycoprotein\u2020\u2020Dedicated to Prof. B. C. Lippold on the occasion of his 60th birthday.","display_name":"Role of P\u2010glycoprotein\u2010mediated secretion in absorptive drug permeabiity: An approach using passive membrane permeability and affinity to P\u2010glycoprotein\u2020\u2020Dedicated to Prof. B. C. Lippold on the occasion of his 60th birthday.","alternate_titles":[],"publication_year":1999,"publication_date":"1999-10-01","ids":{"openalex":"https://openalex.org/W1980418252","doi":"https://doi.org/10.1021/js980378j","mag":"1980418252","pmid":"https://pubmed.ncbi.nlm.nih.gov/10514357"},"language":"en","primary_location":{"id":"doi:10.1021/js980378j","doi":"https://doi.org/10.1021/js980378j","is_oa":false,"landing_page_url":"https://doi.org/10.1021/js980378j","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1980418252"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043371009","display_name":"Stephan D\u00f6ppenschmitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I68956291","display_name":"Martin Luther University Halle-Wittenberg","ror":"https://ror.org/05gqaka33","country_code":"DE","type":"education","lineage":["https://openalex.org/I68956291"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephan Doppenschmitt","raw_affiliation_strings":["School of Pharmacy, Martin Luther-University Halle-Wittenberg, Wolfgang-Langenbeck-Strasse 4, D-06120 Halle (Saale), Germany","Astra H\u00e4ssle AB, PKDM, S\u2010431 83 M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Martin Luther-University Halle-Wittenberg, Wolfgang-Langenbeck-Strasse 4, D-06120 Halle (Saale), Germany","institution_ids":["https://openalex.org/I68956291"]},{"raw_affiliation_string":"Astra H\u00e4ssle AB, PKDM, S\u2010431 83 M\u00f6lndal, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111698981","display_name":"Hilde Spahn-Langguth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I68956291","display_name":"Martin Luther University Halle-Wittenberg","ror":"https://ror.org/05gqaka33","country_code":"DE","type":"education","lineage":["https://openalex.org/I68956291"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hildegard Spahn\u2010Langguth","raw_affiliation_strings":["School of Pharmacy, Martin Luther\u2010University Halle\u2010Wittenberg, Wolfgang\u2010Langenbeck\u2010Strasse 4, D\u201006120 Halle (Saale), Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Martin Luther\u2010University Halle\u2010Wittenberg, Wolfgang\u2010Langenbeck\u2010Strasse 4, D\u201006120 Halle (Saale), Germany","institution_ids":["https://openalex.org/I68956291"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111891972","display_name":"Carl Gunnar Reg\u00e5rdh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carl Gunnar Reg\u00e5rdh","raw_affiliation_strings":["Astra H\u00e4ssle AB, PKDM, S\u2010431 83 M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astra H\u00e4ssle AB, PKDM, S\u2010431 83 M\u00f6lndal, Sweden","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007186343","display_name":"Peter Langguth","orcid":"https://orcid.org/0000-0003-3758-7581","observed_orcids":["https://orcid.org/0000-0003-3758-7581"]},"institutions":[{"id":"https://openalex.org/I197323543","display_name":"Johannes Gutenberg University Mainz","ror":"https://ror.org/023b0x485","country_code":"DE","type":"education","lineage":["https://openalex.org/I197323543"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Peter Langguth","raw_affiliation_strings":["Johannes Gutenberg\u2010University, Staudingerweg 5, D\u201055099 Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johannes Gutenberg\u2010University, Staudingerweg 5, D\u201055099 Mainz, Germany","institution_ids":["https://openalex.org/I197323543"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5007186343"],"corresponding_institution_ids":["https://openalex.org/I197323543"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":2.9457,"has_fulltext":false,"cited_by_count":137,"citation_normalized_percentile":{"value":0.90777961,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"88","issue":"10","first_page":"1067","last_page":"1072"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9789999723434448},{"id":"https://openalex.org/keywords/drug-secretion","display_name":"drug secretion","score":0.6179999709129333},{"id":"https://openalex.org/keywords/passive-membrane-permeability","display_name":"passive membrane permeability","score":0.9509999752044678},{"id":"https://openalex.org/keywords/caco-2-cell-monolayers","display_name":"Caco-2 cell monolayers","score":0.8460000157356262},{"id":"https://openalex.org/keywords/efflux","display_name":"efflux","score":0.39899998903274536},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.7120000123977661},{"id":"https://openalex.org/keywords/talinolol","display_name":"talinolol","score":0.9950000047683716},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.6159999966621399},{"id":"https://openalex.org/keywords/radioligand-binding-assay","display_name":"radioligand binding assay","score":0.7760000228881836},{"id":"https://openalex.org/keywords/drug-flux","display_name":"drug flux","score":0.40400001406669617},{"id":"https://openalex.org/keywords/oral-absorption","display_name":"oral absorption","score":0.6069999933242798},{"id":"https://openalex.org/keywords/p-glycoprotein-inhibitors","display_name":"P-glycoprotein inhibitors","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.745822548866272},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.6692835688591003},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.6416758894920349},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5653983354568481},{"id":"https://openalex.org/C120882062","wikidata":"https://www.wikidata.org/wiki/Q28352","display_name":"Permeability (electromagnetism)","level":3,"score":0.44447293877601624},{"id":"https://openalex.org/C2777459641","wikidata":"https://www.wikidata.org/wiki/Q6815130","display_name":"Membrane glycoproteins","level":3,"score":0.42126303911209106},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41009584069252014},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.3953922390937805},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3602125346660614},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3425975441932678},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1821989119052887},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000042","descriptor_name":"Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002463","descriptor_name":"Cell Membrane Permeability","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011869","descriptor_name":"Radioligand Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/js980378j","doi":"https://doi.org/10.1021/js980378j","is_oa":false,"landing_page_url":"https://doi.org/10.1021/js980378j","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:10514357","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10514357","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W102700214","https://openalex.org/W165862574","https://openalex.org/W258565319","https://openalex.org/W268083967","https://openalex.org/W330545229","https://openalex.org/W1536304252","https://openalex.org/W1551144869","https://openalex.org/W1564279439","https://openalex.org/W1901882391","https://openalex.org/W2006998103","https://openalex.org/W2042066665","https://openalex.org/W2048259367","https://openalex.org/W2077510533","https://openalex.org/W2143808974","https://openalex.org/W2153413276","https://openalex.org/W2162438271","https://openalex.org/W2172134989"],"related_works":["https://openalex.org/W2044831411","https://openalex.org/W1988341201","https://openalex.org/W1501945432","https://openalex.org/W2042066665","https://openalex.org/W1546057338","https://openalex.org/W102700214","https://openalex.org/W1526950891","https://openalex.org/W2151477936","https://openalex.org/W1909691387","https://openalex.org/W2054666684"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1980418252","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
